IL85983A - Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicaments - Google Patents
Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicamentsInfo
- Publication number
- IL85983A IL85983A IL8598388A IL8598388A IL85983A IL 85983 A IL85983 A IL 85983A IL 8598388 A IL8598388 A IL 8598388A IL 8598388 A IL8598388 A IL 8598388A IL 85983 A IL85983 A IL 85983A
- Authority
- IL
- Israel
- Prior art keywords
- carrier protein
- human
- growth
- polypeptide
- somatomedins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3488587A | 1987-04-06 | 1987-04-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL85983A0 IL85983A0 (en) | 1988-09-30 |
| IL85983A true IL85983A (en) | 1994-10-07 |
Family
ID=21879212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL8598388A IL85983A (en) | 1987-04-06 | 1988-04-05 | Human somatomedin carrier protein subunits, antibodies against them, pharmaceutical compostitions containing them and their use in the preparation of medicaments |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP0308500B1 (da) |
| JP (1) | JP2648951B2 (da) |
| AT (1) | ATE90690T1 (da) |
| AU (1) | AU627423B2 (da) |
| CA (1) | CA1340295C (da) |
| DE (1) | DE3881801T2 (da) |
| DK (1) | DK677688D0 (da) |
| ES (1) | ES2058341T3 (da) |
| IL (1) | IL85983A (da) |
| WO (1) | WO1988007863A1 (da) |
| ZA (1) | ZA882407B (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5973115A (en) * | 1987-05-15 | 1999-10-26 | Amgen Inc. | Method for potentiating and inhibiting insulin-like growth factor activity |
| US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
| JPH03504597A (ja) * | 1988-04-12 | 1991-10-09 | シナージェン，インコーポレーテッド | インスリン様成長因子活性の強化および阻害方法 |
| CA1341598C (en) * | 1988-07-15 | 2009-09-29 | Central Sydney Area Health Service | Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| US6465423B1 (en) | 1988-07-15 | 2002-10-15 | Central Sydney Area Health Service | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| US5324820A (en) * | 1988-07-15 | 1994-06-28 | Central Sydney Area Health Service | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| US5187151A (en) * | 1991-02-12 | 1993-02-16 | Genentech, Inc. | Use of binding protein with igf-i as an anabolic growth promoting agent |
| WO1996002565A1 (en) * | 1994-07-20 | 1996-02-01 | Celtrix Pharmaceuticals, Inc. | Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
| US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
| US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
| DK1141014T3 (da) | 1999-01-06 | 2005-04-11 | Genentech Inc | Insulinlignende vækstfaktor (IGF) i mutantvariant |
| AU762047B2 (en) | 1999-01-06 | 2003-06-19 | Genentech Inc. | Insulin-like growth factor (IGF) I mutant variants |
| ES2301547T3 (es) | 2000-05-16 | 2008-07-01 | Genentech, Inc. | Tratamiento de trastornos del cartilago. |
| US7071300B2 (en) | 2001-03-14 | 2006-07-04 | Genentech, Inc. | IGF antagonist peptides |
| WO2005016970A2 (en) | 2003-05-01 | 2005-02-24 | Imclone Systems Incorporated | Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| ES2541673T3 (es) | 2003-09-12 | 2015-07-23 | Ipsen Biopharmaceuticals, Inc. | Métodos para el tratamiento de la deficiencia de factor 1 de crecimiento similar a la insulina (IGF-1) |
| WO2005033132A2 (en) | 2003-10-03 | 2005-04-14 | Genentech, Inc. | Igf binding proteins |
| BRPI0611984A2 (pt) | 2005-06-17 | 2009-07-07 | Imclone Systems Inc | uso de anticorpos igf-ir para fabricação de um medicamento para tratar um tumor ósseo |
| JP5198289B2 (ja) | 2006-02-03 | 2013-05-15 | イムクローン・リミテッド・ライアビリティ・カンパニー | 前立腺癌の治療用アジュバントとしてのｉｇｆ−ｉｒアンタゴニスト |
| MX2020002744A (es) | 2017-09-11 | 2020-10-01 | Takeda Pharmaceuticals Co | Metodos y composiciones para tratar enfermedades pulmonares cronicas. |
| AU2021364523A1 (en) | 2020-10-19 | 2023-04-06 | Oak Hill Bio Limited | Compositions suitable for use in neonates |
| WO2023139115A1 (en) | 2022-01-19 | 2023-07-27 | Oak Hill Bio Limited | Compositions and methods for reducing oxidation of igf‐1/igfbp |
| WO2023242440A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Treament of lungs in infants |
| WO2023242439A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Vascular stabilisation (preterm infants) |
| WO2023242442A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Method of maturing/differentiating neurons and/or modulating the vagus nerve |
-
1988
- 1988-03-31 JP JP63503623A patent/JP2648951B2/ja not_active Expired - Lifetime
- 1988-03-31 AT AT88904042T patent/ATE90690T1/de active
- 1988-03-31 DE DE88904042T patent/DE3881801T2/de not_active Expired - Fee Related
- 1988-03-31 EP EP88904042A patent/EP0308500B1/en not_active Expired - Lifetime
- 1988-03-31 WO PCT/US1988/001042 patent/WO1988007863A1/en active IP Right Grant
- 1988-03-31 ES ES88904042T patent/ES2058341T3/es not_active Expired - Lifetime
- 1988-03-31 AU AU17020/88A patent/AU627423B2/en not_active Ceased
- 1988-04-05 IL IL8598388A patent/IL85983A/en unknown
- 1988-04-05 CA CA000563309A patent/CA1340295C/en not_active Expired - Fee Related
- 1988-04-06 EP EP88303041A patent/EP0294021A1/en active Pending
- 1988-04-07 ZA ZA882407A patent/ZA882407B/xx unknown
- 1988-12-05 DK DK677688A patent/DK677688D0/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2648951B2 (ja) | 1997-09-03 |
| EP0294021A1 (en) | 1988-12-07 |
| DK677688A (da) | 1988-12-05 |
| ZA882407B (en) | 1988-09-28 |
| EP0308500B1 (en) | 1993-06-16 |
| AU1702088A (en) | 1988-11-04 |
| WO1988007863A1 (en) | 1988-10-20 |
| DE3881801T2 (de) | 1993-12-23 |
| EP0308500A1 (en) | 1989-03-29 |
| DE3881801D1 (de) | 1993-07-22 |
| DK677688D0 (da) | 1988-12-05 |
| ATE90690T1 (de) | 1993-07-15 |
| CA1340295C (en) | 1998-12-29 |
| JPH01502986A (ja) | 1989-10-12 |
| IL85983A0 (en) | 1988-09-30 |
| ES2058341T3 (es) | 1994-11-01 |
| AU627423B2 (en) | 1992-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0308500B1 (en) | Human somatomedin carrier protein subunits and process for producing them | |
| US5200509A (en) | Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides | |
| Zapf et al. | Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders | |
| CA2006322C (en) | Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides | |
| JPH03506030A (ja) | インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ） | |
| JP2819467B2 (ja) | 新規なカルジオジラチン断片およびその製造方法 | |
| BREUER | Stimulation of DNA Synthesis in Cartilage of Modified Placental Lactogen and Anabolic Hormones | |
| JP2527896B2 (ja) | ヒト骨由来インスリン様成長因子結合タンパク | |
| JPH11506337A (ja) | 骨刺激因子 | |
| DEVITO | Comparison of brain and pituitary immunoreactive prolactin by peptide mapping and lectin affinity chromatography | |
| Robbins et al. | Products of therapeutic insulins in the blood of insulin-dependent (type I) diabetic patients | |
| WO2003102180A1 (fr) | Nouveaux peptides avec activite de production de camp | |
| JP2803184B2 (ja) | 酸性線維芽細胞成長因子の抗体，その用途およびペプチド | |
| Ooi et al. | Recognition of insulin-like-growth-factor-binding proteins in serum and amniotic fluid by an antiserum against a low-molecular-mass insulin-like-growth-factor-inhibitor/binding protein | |
| JP2562892B2 (ja) | インスリン結合活性を有するポリペプチド | |
| WO1996019501A1 (en) | Modulators of bone cell function and uses thereof | |
| HARTREE | Chapter Preparation and 0ne Properties of Human Growth Hormone | |
| Brems et al. | Asp B1 insulin analogs |